Skip to main content

Hypoxia clinical trials at UC Davis

2 research studies open to eligible people

Showing trials for
  • Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy

    open to all eligible people

    The goal is to see whether topiramate (an anti-epileptic agent) improves the outcome of babies with neonatal hypoxic encephalopathy who are receiving whole body cooling.

    Sacramento, California

  • THRIVE Use in Pediatric Populations- Multi Site

    open to eligible people ages up to 18 years

    THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can prevent desaturation events in children under anesthesia and improve the outcomes of that surgery.

    Palo Alto, California and other locations

Our lead scientists for Hypoxia research studies include .

Last updated: